Background: IgE/anti-IgE immune complexes (IgE-IC) induce the release of multiple mediators from monocytes/macrophages and the monocytic cell line U937 following the ligation of the low-affinity Fcs receptors (FcsRIIICD23). These effects are mediated through an accumulation of cAMP and the generation of L-arginine-dependent nitric oxide (NO). Since high IgE levels predict more rapid progression to acquired immunodeficiency syndrome, we attempted to define the effects of IgE-IC on human immunodeficiency virus (HIV) production in monocytes. Materials and Methods: Two variants of HIV-1 chronically infected monocytic U1 cells were stimulated with IgE-IC and virus replication was quantified. NO and cAMP involvement was tested through the use of agonistic and antagonistic chemicals of these two pathways.
INTRODUCTION
It is now well established that in addition to T cells, monocytes/macrophages play a central role in the pathogenesis of acquired immunodefi-F. Ouaaz et al.: IgE Effects on HIV-l+ Monocytes seen in AIDS. Even in the lymph nodes, where virus is continually produced (7, 10) , most T cells and macrophages containing provirus do not have detectable viral mRNA (7) . It is clear that the macrophage serves as a viral reservoir, since HIV has been detected in tissue macrophages of many organs.
It is interesting that Con A-activated T cells can reactivate expression of latent virus in monocytes obtained from AIDS patients (6) , suggesting that immune activation can play a role in HIV pathogenesis. In various human immune responses, IgE levels increase and correlate with an enhancement of in situ infiltration by hemopoietic effector cells and the release of multiple mediators from these cells (11) (12) (13) (14) (15) (16) (17) . Allergy and IgE levels are not dramatically elevated in HIV patients, but high IgE levels predict more rapid progression to AIDS (18) (19) (20) .
IgE and antigen directly activate the secretion of various cytokines from mast cells following cross-linking of the high-affinity receptor, FceRI (12, 13) . IgE/antigen also induce the synthesis and the release of tumor necrosis factor a (TNFa) and other mediators from the human mononuclear phagocytic cell lineage (14) (15) (16) (17) . These cells are potent effectors of inflammation through their capacity to secrete preformed and newly synthesized monokines, respiratory burst products, and arachidonate metabolites (21) .
Although monocytes/macrophages are a main reservoir of HIV-1, the role of IgE on HIVinfected cells and AIDS pathogenesis remains unclear. Monocytes/macrophages have a restricted FEcRI expression (22) , but can easily bind IgE following expression of a specific isoform of the lowaffinity receptor CD23b/FcsRll, undetected in mice (17, 23, 24) . Recently, we have shown that CD23b is a functional IgE receptor on normal human monocytes and U937 cells (17, 25) . Ligation of CD23 by IgE/anti-IgE or specific monoclonal antibody (mAb) induces various monocyte functions through two second messengers: cAMP and nitric oxide (NO) (17, 25, 26) . In the present study, we attempted to define the role of IgE-anti-IgE immune complexes (IgE-IC) on HIV production in monocytes using two variants of the HIV-1 chronically infected monocytic Ul cells (a clone of U937). Our data point to a regulatory role of IgE-IC on HIV production in monocytic cells, through CD2 3-mediated stimulation of cAMP and NO pathways. In addition, we suggest that IgE-IC can stimulate increased cell death in high HIV producing cells through the NO pathway. (27) . The mAb 135 have better specificity than mAb 25 in recognizing the IgE-binding site of CD23 (27) and, in its Fab form, to prevent CD23 cross-linking with no cell activation (17, 28) .
MATERIALS AND METHODS

Reagents
Cells
Ul cells with low p24 production levels (<250 pg/ 105 cells/ml in 3-day supernatants) designed later as U 110w were a gift of T. Folks (CDC, Atlanta, GA, U.S.A.). They do not express CD23 (<4% (6, 30) . TNFa measurement was performed by ELISA (Genzyme, Cambridge, MA, U.S.A.). Stable end product of NO, NO2-, was assayed using Greiss reaction modified as detailed elsewhere (31) . Cell surface phenotype was assayed using immunofluorescence with FITC-conjugated mAb from Immunotech as previously described (25) . Nonspecific butyrate esterase and its inhibition by sodium fluoride were performed as detailed elsewhere (25 (35) . Thirty amplification cycles were carried out using a thermocycler (Perkin Elmer Cetus), denaturing at 940C for 1 min, annealing at 55°C for 1 min, and extending at 720C for 2 min, followed by liquid hybridization as described (32) . Probes used were SK19 HIV gag (1587-1627) and GAPDH (514-532). Analysis of hybridized products was visualized on a 8% nondenaturing acrylamide/IX TAE gel and exposure to Kodak XAR-5 film at -50°C for 1-2 hr (with intensifying screens). Amplification products were quantified on a densitometer (Molecular Dynamics, Sunnyvale, CA, U.S.A.) using the GPDH as a control.
RESULTS
IgE-IC Enhances HIV Replication in IL-4-or IL-13-Treated Ul Cells
The effect of IgE-IC on p24 production by UllOW cells was assayed. UllOW cells were also pretreated with IL-4 or IL-13 prior to incubation with IgE-IC. In fact, we have recently shown (17) that these cytokines are necessary to induce IgE responses in the monocyte/macrophage lineage, probably through the induction of FceRII (see below). As shown in Fig. 1 , sequential treatment of Ul cells with IL-4 or IL-13 for 48 hr, then IgE-IC resulted in a significant induction of p24 levels (p < 0.003). Treatment with IL-4 or IgE-IC alone had no effect on p24 levels over three days of incubation, while IL-13 caused a suppression in p24 levels (Fig. 1B) . To determine the role of IgE-IC on HIV-1 transcription, we treatmenit of Ul cells with CD23-Fab, and not an isotype nmatched mAb (CD19-mAb), inhibits the effects of IgE-IC on p24 production by these cells.
Furthermore, treatment of IL-4 induced Ullow cells with CD23-mAb + anti-mouse Ig (MIg) induces significant increases in p24 levels (p < 0.02) (Fig. 4) . Anti-MIg was used in order to induce the crosslinkage of surface CD23, necessary to obtain optimal monocyte activation. No such effect was observed with anti-MIg alone or with an isotype-matched control inAb (CD19) (Fig. 4) (17, 25, 26, 28) . The respective role of each of these intracellular events in IgE-dependent enhancement of p24 production in Ul"" cells was then assayed. Biochemical modulators of these factors were added to the cells prior to the treatment with IgE-IC. The inhibition of cAMP pathway by Rp-cAMP significantly reversed IgE -IC-dependent enhancement of p24 (p < 0.004) (Fig. 5A) . Furthermore, addition of cAMP agonistic analogue (Dibut-cAMP) greatly enhanced the extracellular p24 levels in botlh untreated and IgE-IC-treated cells in a dose-dependent manner (Fig. 5B) Fig. 1 (Fig. 5A) . SOD + catalase also inhibits p24 enhancement by SIN-I (Fig. 5A ). The addition of both RpcAMP and L-NMMA completely reversed IgE-IC induced p24 production in Ullw cells (Fig. 5A ).
In addition to p24 induction and as in U937 cells, (Table 2) . They produce higher p24 (>2.5 ng/ml) and TNFa (>235 pg/ ml) levels after IgE-IC incubation ( (Fig. 6) . In contrast to Ul"w cells, 48-hr Ulhigh cell incubation with IgE-IC resulted in a significant decrease of p24 levels, correlating with decreases of the viable cell numbers recovered from these culture (Fig. 6 ). (Fig. 7) . Finally, the addition of neutralizing anti-TNFa had no effect on IgE-IC function (Fig. 7) cell surface and low production of TNFa and HIV ( Fig. 1 and Table 1 ), IgE-IC increased the production of HIV and the production of p24. This tion of Dibut-cAMP did not modify effect was dose dependent, and required the exs (Fig. 7) but increased p24 levels pression of CD23 on the surface of UlloW cells 0.3 to 2.4 ± 0.5 ng/ml). By contrast, (Fig. 4) . CD23 expression could easily be ob-I of L-NMMA or SOD + catalase tained following cell treatment with various shed the accelerated cell death stimphysiologic factors: IL-4, IL-13, GM-CSF, or iE-IC (Fig. 7) . L-NMMA effect was IFN-,y (25, 36, 40) (Fig. 3) . We also assayed the ough the addition of L-arginine but effect of IgE-IC on a variant of Ul cells with high ne to the cultures (data not shown), HIV transcription and p24 levels (UIhigh). (56) (57) (58) , it seems to be a stimulatory pathway for HIV infection and thus may contribute to HIV pathogenesis. HIV products may be induced by peroxynitrites directly (as potent oxygen radicals) (59) or indirectly through their ability to induce TNFa production by these cells (Fig. 5) . The similarity between p24 inhibition by L-NMMA and by anti-TNFa is in favor of the role of this cytokine in this IgE-IC effect. Nitrogen radicals and TNFa are potent inducers of the transcription factor NFKB in various cells (60, 61) including U937 cells (25) . Of interest, anti-viral effects of NO were found on viruses (56) (57) (58) which, by contrast to HIV, do not contain KB sites. This hypothesis corroborates with Chowdhury et al. work (53) , which showed the synergy between cAMP and TNFa in stimulating HIV-1 from chronic low-level HIV production in cells of monocyte/macrophage lineage.
Induction of nitric oxide synthase was observed in asthma (62) , which corroborates with the role of NO in proviral effect of IgE-IC. NO generation by human monocytes was also observed following their activation with gp 120 (63). Bukrinsky et al. recently showed that HIV infection promoted the generation of NO in human monocytes (64) , and that NO mediates neu-rotoxicity in HIV-infected patients (63, 64) . While the precise mechanism(s) of NO effects remain(s) to be clarified, above data make likely the involvement of NO in HIV pathogenesis. the immunoregulatory role of macrophages and other accessory cells. Science 236: 551-
